home / stock / cprx / cprx news


CPRX News and Press, Catalyst Pharmaceuticals Inc. From 05/21/21

Stock Information

Company Name: Catalyst Pharmaceuticals Inc.
Stock Symbol: CPRX
Market: NASDAQ
Website: catalystpharma.com

Menu

CPRX CPRX Quote CPRX Short CPRX News CPRX Articles CPRX Message Board
Get CPRX Alerts

News, Short Squeeze, Breakout and More Instantly...

CPRX - Catalyst Pharmaceuticals Inc. Looks to Continue to Trade Above its Annual-High Share Price Today

Catalyst Pharmaceuticals Inc. (NASDAQ:CPRX) traded at a new 52-week high today of $5.81. Approximately 109,000 shares have changed hands today, as compared to an average 30-day volume of 1.3 million shares. Catalyst Pharmaceuticals Inc. share prices have moved between a 52-week high of $...

CPRX - Shares of Catalyst Pharmaceuticals Inc. (CPRX) Rise Above Previous 52-Week High

Shares of Catalyst Pharmaceuticals Inc. (NASDAQ:CPRX) traded at a new 52-week high today of $5.61. This new high was reached on below average trading volume as 109,000 shares traded hands, while the average 30-day volume is approximately 1.3 million shares. Catalyst Pharmaceuticals Inc. ...

CPRX - Catalyst Pharmaceuticals to Participate in Two Upcoming Investor Conferences

CORAL GABLES, Fla., May 19, 2021 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. (Catalyst) (Nasdaq:CPRX), a commercial-stage, patient-centric biopharmaceutical company focused on in-licensing, developing and commercializing novel high-quality medicines for patients living with rare dise...

CPRX - Catalyst Pharmaceuticals Inc (CPRX) Q1 2021 Earnings Call Transcript

Image source: The Motley Fool. Catalyst Pharmaceuticals Inc (NASDAQ: CPRX) Q1 2021 Earnings Call May 11, 2021 , 8:30 a.m. ET Operator Continue reading For further details see: Catalyst Pharmaceuticals Inc (CPRX) Q1 2021 Earnings Call Tran...

CPRX - Catalyst Pharmaceuticals' (CPRX) CEO Patrick McEnany on Q1 2021 Results - Earnings Call Transcript

Catalyst Pharmaceuticals, Inc. (CPRX) Q1 2021 Earnings Conference Call May 11, 2021 8:30 AM ET Company Participants Alicia Grande – Vice President, Chief Financial Officer and Treasurer Patrick McEnany – Chairman and Chief Executive Officer Jeffrey Del Carmen – Chief Comm...

CPRX - Catalyst Pharmaceuticals Announces First Quarter 2021 Financial Results and Provides Business Update

-Firdapse® Q1 2021 Net Revenues of $30.2 Million -First Quarter 2021 GAAP Net Income of $7.7 Million; Non-GAAP Net Income of $11.6 Million -Recently Received Orphan Drug Designation for Firdapse® in Japan -$143.3 Million in Cash and Investments and no Fun...

CPRX - This Under-the-Radar Pharma Company's Recent Success Is Just the Beginning

For under-the-radar companies, it's important to make sure any positive news finds its way to the eyes or ears of investors. The first quarter of 2021 is evidence of that for one small player dedicated to treating rare diseases in the pharmaceutical market. Catalyst Pharmaceuticals (N...

CPRX - Catalyst Pharmaceuticals to Hold First Quarter 2021 Financial Results and Corporate Update Conference Call and Webcast on Tuesday, May 11th, 2021

CORAL GABLES, Fla., May 03, 2021 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. (Catalyst) (Nasdaq: CPRX), a commercial-stage, patient-centric biopharmaceutical company focused on in-licensing, developing and commercializing novel high-quality medicines for patients living with rare dis...

CPRX - The 'Value' Strikes Back - Value Strategies' Performance Through COVID

It has been one year since the markets bottomed in March of 2020 due to COVID. Markets have rebounded beyond most investors’ expectations, with growth and tech stealing much of the spotlight. The “rotation into value” narrative has recently gained some tractio...

CPRX - 3 Healthcare Stocks That Could Be Millionaire-Makers

Supernus Pharmaceuticals (NASDAQ: SUPN) , Corcept Therapeutics (NASDAQ: CORT) , and Catalyst Pharmaceuticals (NASDAQ: CPRX) don't have much in common. But it does so happen that they're all in the healthcare space, trade for less than $26 per share, and have the pote...

Previous 10 Next 10